Sunday, September 13, 2026

Seoul St. Mary’s Prof. Jang Ki-yuk Selected as Sole Applied Medicine Researcher in National Leader Program

Prof. Jang Ki-yuk of Seoul St. Mary's Hospital receives $5.2M for cardiovascular disease research, focusing on plaque regression.

Digital Iron Curtain: New Smartphone ATMs Give Kim Total Control Over Economy and Citizens

North Korea sees a rise in smartphone use and electronic payments, with ATMs allowing cash withdrawals via smartphones.

North Korea’s Military Strategy: Is Kaesong Becoming a Military Base?

North Korea's document reveals plans to militarize the Kaesong Industrial Complex, emphasizing its strategic military importance against perceived enemies.

Tag: trial

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Navigating FDA Challenges: How SK Biopharmaceuticals Plans to Move Forward with Opacalim

SK Biopharm will maintain its development and commercialization plans for epilepsy drug candidate Opacalim despite FDA's partial clinical hold.

GC Pharma Wins Approval for Phase 2 Trial of COVID-19 mRNA Vaccine

GC Pharma has received approval for a Phase 2 trial of its COVID-19 mRNA vaccine candidate GC4006A and plans to advance toward Phase 3 while expanding the platform into other disease areas.

South Korea Begins Its First Advanced Regenerative Medicine Treatment Using ViGenCell Therapy

ViGenCell’s VT-EBV-N has begun South Korea’s first approved advanced regenerative medicine treatment, giving patients with high-risk EBV-positive lymphoma access to a personalized T-cell therapy while generating real-world clinical and manufacturing data.

JNP Medi’s Maven Converter Nominated for Prix Galien Korea 2026: A Game-Changer in Clinical Trials?

JNP Medi's Maven Converter has been nominated for the Prix Galien Korea 2026, the first global pharma and biotech awards in Korea.

HLB Therapeutics’ RGN-259: What to Expect from the Upcoming Topline Results in November 2026?

HLB Therapeutics completed the last patient visit for its RGN-259 treatment in the global Phase 3 trial for neurotrophic keratitis.

JW Pharmaceutical Files for South Korea Phase 3 Trial of Once-Every-Two-Weeks Obesity Drug

JW Pharmaceutical is seeking to advance Bofanglutide into a South Korean Phase 3 trial, aiming to halve the dosing frequency of GLP-1 obesity treatments from once weekly to once every two weeks.

BMI2012: South Korea’s Next-Gen mRNA COVID-19 Vaccine Set for Clinical Trials

A consortium has received approval for the clinical trial of an mRNA-based COVID-19 variant vaccine, BMI2012.

JP-2266: The Next-Gen Diabetes Treatment Revolutionizing Blood Sugar Control in Asia

Jeil Pharmaceutical's JP-2266 shows significant blood sugar improvement in phase II trials, with benefits in weight loss and cardiovascular health.

AriBio Completes Global Phase 3 Trial of Alzheimer’s Drug AR1001, Awaits Topline Results

AriBio completes final patient follow-up in Phase 3 trial for Alzheimer's treatment AR1001, entering data analysis phase.

Kolon Group’s Biotech Bet Faces Uncertainty as October Trial Readout Becomes Critical

Kolon TissueGene's TG-C osteoarthritis treatment failed its first U.S. Phase 3 trial, raising doubts about the biotech's future.

Kolon TissueGene Says TG-C Fails to Meet Statistical Significance in First Phase 3 Trial Analysis in U.S.

Kolon TissueGene's Phase 3 trial for TG-C showed pain relief but lacked statistical significance compared to placebo; further analysis underway.

Belvarafenib: The Promising New Targeted Cancer Drug for NRAS Mutant Melanoma

Hanmi Pharmaceutical presents Belvarafenib's phase 2 trial for NRAS mutant melanoma at KCA 2026, targeting unmet medical needs.

L&K Biomed’s BlueX-C: First Clinical Success in the U.S. Spine Implant Market!

L&K Biomed's BlueX-C cervical cage achieves FDA approval and successful clinical application, signaling strong market potential in the U.S.

Bukwang Pharmaceutical builds turnaround momentum, eyes Parkinson’s drug progress in second half

Bukwang Pharmaceutical is advancing its Parkinson’s treatment CP-012 into a global Phase 2 trial while enhancing RNA technology and manufacturing.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.